Back to search

Article

Sacubitril-valsartan in Heart Failure With Preserved Ejection Fraction Following Acute Coronary Syndrome

2021-09-23

Abstract excerpt

<h4>Background: </h4> It was indicated that sacubitril-valsartan could improve the clinical prognosis in specific phenotype of heart failure with preserved ejection fraction (HFpEF) patients compared with valsartan. However, there is lack of evidence of the comparative effectiveness in HFpEF patients following acute coronary syndrome (ACS). The aim of this study was to evaluate whether the selection between sacubi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52a29326-c307-5502-879e-69ab4caeb8b1
DOI
10.21203/rs.3.rs-917223/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sacubitril-valsartan in Heart Failure With Preserved Ejection Fraction Following Acute Coronary SyndromeDOI 10.21203/rs.3.rs-917223/v1
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction SpectrumSemantic proximity
Sacubitril-Valsartan and Its Results for the Treatment of Heart Failure with Preserved and Mildly Reduced Ejection FractionSemantic proximity
Efficacy and safety of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotensionSemantic proximity
Patient-level comparison of heart failure patients in clinical phenotype and prognosis from China and Sweden.Semantic proximity
Cardiovascular drugs approved for heart failure with reduced ejection fraction and/or post-myocardial infarction exert consistent effects in both populations: A meta-analysis and meta-regression of randomized controlled trialsSemantic proximity
SGLT2i, ARNi and Diuretic Use in Patients with Heart Failure Among the Preserved and Reduced Ejection Fraction: A Retrospective Observational StudySemantic proximity
Clinical Evidence of Initiating a Very Low Dose of Sacubitril/Valsartan; Beyond the PARADIGM-HF and PIONEER-HF: A Prospective Observational AnalysisSemantic proximity
Recent advances in the treatment of chronic heart failureSemantic proximity
Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment.Semantic proximity
Clinical efficacy of sacubitril/valsartan in maintenance hemodialysis patients with HFpEFSemantic proximity
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.Semantic proximity
Real-World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta-Analysis.Semantic proximity
Select a neighboring publication to make it the new centre.